Pancreatic Cancer
Strategy utilizes fibroblast growth factor receptors for targeting cancer
Published in Gene Therapy Weekly, July 25th, 2002
Pancreatic cancer is one of the disease's deadliest forms. According to estimates from the American Cancer Society, approximately 30,000 people in the U.S. will be diagnosed with pancreatic cancer in the year 2002, and nearly 30,000 people will die from it. University of California at Irvine researchers predict FGFRs may be important in suicide gene therapies used alone or in combination with other treatment modalities for treating PDAC. Such therapies have the potential to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2002-07-25)
More Articles from Gene Therapy Weekly
- Antisense Gene Therapy
Blocking integrin subunits could refine approach to cancer treatment - Liver Therapy
Vector dampens liver cell resistance to gene therapy - Lung Cancer
Certain retinoids able to override nicotine effects better than others - Ovarian Cancer
Multiple dose gene therapy yields best results in recurrent ovarian cancer - Appointments
Psychiatric Genomics, Inc., names Bradley Lorimier to board of directors - Cancer Therapy
St. Jude study shows gene therapy offers hope to chemotherapy patients - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
